Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Non-indocyanine green angiography non-invasive differentiating features in the differential diagnosis of pachychoroid neovasculopathy and neovascular age-related macular degeneration: a sensitivity-specificity study

Abstract

Objectives

To define the differentiating features of pachychoroid neovasculopathy (PNV) and neovascular age-related macular degeneration (nAMD) without dye angiography.

Methods

This study included treatment-naive 50 PNV patients and 50 nAMD patients with unilateral Type 1 macular neovascularisation (MNV). The studied optical coherence tomography (OCT) features were subretinal hyperreflective material, intraretinal cysts, choroidal thickness (CT), pigment epithelial detachment (PED), retinal pigment epithelium (RPE) changes, and types of drusen. The choroidal vascularity index (CVI) was calculated. Intervortex venous anastomosis, MNV subtypes, and the main trunk appearance on OCT angiography (OCTA) were evaluated. Features with an area under the receiver operating characteristic curve (AUC) above 0.75 were defined as major, while those between 0.60 and 0.75 were defined as minor differentiating features.

Results

Five features met the criteria for major differentiating features: age ≤60 years, SFCT ≥ 254 µm in the diseased eye, CVI ≥ 72% in the diseased eye, SFCT ≥ 323 µm in the fellow eye, and the absence of soft drusen. Six features met the criteria for minor differentiating features: CVI ≥ 74% in the fellow eye, absence of serous PED, absence of reticular drusen, presence of intervortex anastomoses, presence of immature MNV, and absence of the main trunk on OCTA. The sensitivity, specificity, positive predictive value, negative predictive value, and AUC for at least three major and at least three minor differentiating features are 0.88, 0.96, 0.96, 0.89, and 0.92, respectively.

Conclusion

At least three major and three minor criteria must be present to confidently diagnose PNV.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Demostration of differences in choroidal vascular structures between two distinct patients, one with pachychoroid neovascupathy (PNV) and the other age-related macular degeneration (AMD), using multimodal imaging.
Fig. 2: Results of the receiver operating characteristic (ROC) curve analysis to define major differentiating features regarding the diagnosis of pachychoroid neovasculopathy.

Similar content being viewed by others

Data availability

The datasets generated during and /or analysed during the current study are available from the corresponding author on reasonable request.

References

  1. Vyawahare H, Shinde P. Age-related macular degeneration: epidemiology, pathophysiology, diagnosis, and treatment. Cureus. 2022;14:e29583.

    PubMed  PubMed Central  Google Scholar 

  2. Constable I, Shen WY, Rakoczy E. Emerging biological therapies for age-related macula degeneration. Expert Opin Biol Ther. 2005;5:1373–85.

    Article  PubMed  CAS  Google Scholar 

  3. Farazdaghi MK, Ebrahimi KB. Role of the choroid in age-related macular degeneration: a current review. J Ophthalmic Vis Res. 2019;14:78–87.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, et al. Consensus nomenclature for reporting neovascular age-related macular degeneration data: consensus on neovascular age-related macular degeneration nomenclature study group. Ophthalmology. 2020;127:616–36.

    Article  PubMed  Google Scholar 

  5. Jung JJ, Chen CY, Mrejen S, Gallego-Pinazo R, Xu L, Marsiglia M, et al. The incidence of neovascular subtypes in newly diagnosed neovascular age-related macular degeneration. Am J Ophthalmol. 2014;158:769–79.e2.

    Article  PubMed  Google Scholar 

  6. Spaide RF, Gemmy Cheung CM, Matsumoto H, Kishi S, Boon CJF, van Dijk EHC, et al. Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res. 2022;86:100973.

    Article  PubMed  CAS  Google Scholar 

  7. Sakurada Y, Leong BCS, Parikh R, Fragiotta S, Freund KB. Association between choroidal caverns and choroidal vascular hyperpermeability in eyes with pachychoroid diseases. Retina. 2018;38:1977–83.

    Article  PubMed  Google Scholar 

  8. Dansingani KK, Balaratnasingam C, Naysan J, Freund KB. En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography. Retina. 2016;36:499–516.

    Article  PubMed  Google Scholar 

  9. Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015;35:1–9.

    Article  PubMed  CAS  Google Scholar 

  10. Fung AT, Yannuzzi LA, Freund KB. Type 1 (sub-retinal pigment epithelial) neovascularization in central serous chorioretinopathy masquerading as neovascular age-related macular degeneration. Retina. 2012;32:1829–37.

    Article  PubMed  Google Scholar 

  11. Miyake M, Ooto S, Yamashiro K, Takahashi A, Yoshikawa M, Akagi-Kurashige Y, et al. Pachychoroid neovasculopathy and age-related macular degeneration. Sci Rep. 2015;5:16204.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Dansingani KK, Balaratnasingam C, Klufas MA, Sarraf D, Freund KB. Optical coherence tomography angiography of shallow irregular pigment epithelial detachments in pachychoroid spectrum disease. Am J Ophthalmol. 2015;160:1243–54.e2.

    Article  PubMed  Google Scholar 

  13. Demirel S, Yanik O, Nalci H, Batioglu F, Ozmert E. The use of optical coherence tomography angiography in pachychoroid spectrum diseases: a concurrent comparison with dye angiography. Graefes Arch Clin Exp Ophthalmol. 2017;255:2317–24.

    Article  PubMed  Google Scholar 

  14. Braaf B, Vienola KV, Sheehy CK, Yang Q, Vermeer KA, Tiruveedhula P, et al. Real-time eye motion correction in phase-resolved OCT angiography with tracking SLO. Biomed Opt Express. 2013;4:51–65.

    Article  PubMed  Google Scholar 

  15. Spaide RF, Fujimoto JG, Waheed NK, Sadda SR, Staurenghi G. Optical coherence tomography angiography. Prog Retin Eye Res. 2018;64:1–55.

    Article  PubMed  Google Scholar 

  16. Bicer O, Demirel S, Yavuz Z, Batioglu F, Ozmert E. Comparison of morphological features of type 1 CNV in AMD and pachychoroid neovasculopathy: an OCTA study. Ophthalmic Surg Lasers Imaging Retin. 2020;51:640–7.

    Article  Google Scholar 

  17. Azar G, Wolff B, Mauget-Faysse M, Rispoli M, Savastano MC, Lumbroso B. Pachychoroid neovasculopathy: aspect on optical coherence tomography angiography. Acta Ophthalmol. 2017;95:421–7.

    Article  PubMed  Google Scholar 

  18. Spaide RF. Disease expression in nonexudative age-related macular degeneration varies with choroidal thickness. Retina. 2018;38:708–16.

    Article  PubMed  Google Scholar 

  19. Lee J, Byeon SH. Prevalence and clinical characteristics of pachydrusen in polypoidal choroidal vasculopathy: multimodal image study. Retina. 2019;39:670–8.

    Article  PubMed  Google Scholar 

  20. Takahashi A, Hosoda Y, Miyake M, Miyata M, Oishi A, Tamura H, et al. Clinical and genetic characteristics of pachydrusen in eyes with central serous chorioretinopathy and general Japanese individuals. Ophthalmol Retin. 2021;5:910–7.

    Article  Google Scholar 

  21. Hage R, Mrejen S, Krivosic V, Quentel G, Tadayoni R, Gaudric A. Flat irregular retinal pigment epithelium detachments in chronic central serous chorioretinopathy and choroidal neovascularization. Am J Ophthalmol. 2015;159:890–903.e3.

    Article  PubMed  Google Scholar 

  22. Kuranami A, Maruko R, Maruko I, Hasegawa T, Iida T. Pachychoroid neovasculopathy has clinical properties that differ from conventional neovascular age-related macular degeneration. Sci Rep. 2023;13:7379.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  23. Cheung CMG, Lee WK, Koizumi H, Dansingani K, Lai TYY, Freund KB. Pachychoroid disease. Eye (Lond). 2019;33:14–33.

    Article  PubMed  Google Scholar 

  24. Savastano MC, Rispoli M, Savastano A, Lumbroso B. En face optical coherence tomography for visualization of the choroid. Ophthalmic Surg Lasers Imaging Retin. 2015;46:561–5.

    Article  Google Scholar 

  25. Shiihara H, Sonoda S, Terasaki H, Kakiuchi N, Yamashita T, Uchino E, et al. Quantitative analyses of diameter and running pattern of choroidal vessels in central serous chorioretinopathy by en face images. Sci Rep. 2020;10:9591.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Matsumoto H, Hoshino J, Mukai R, Nakamura K, Kikuchi Y, Kishi S, et al. Vortex vein anastomosis at the watershed in pachychoroid spectrum diseases. Ophthalmol Retin. 2020;4:938–45.

    Article  Google Scholar 

  27. Mendonca LSM, Perrott-Reynolds R, Schwartz R, Madi HA, Cronbach N, Gendelman I, et al. Deliberations of an international panel of experts on OCT angiography nomenclature of neovascular age-related macular degeneration. Ophthalmology. 2021;128:1109–12.

    Article  PubMed  Google Scholar 

  28. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33:159–74.

    Article  PubMed  CAS  Google Scholar 

  29. Spaide RF, Koizumi H, Pozzoni MC. Enhanced depth imaging spectral-domain optical coherence tomography. Am J Ophthalmol. 2008;146:496–500.

    Article  PubMed  Google Scholar 

  30. Sonoda S, Sakamoto T, Yamashita T, Shirasawa M, Uchino E, Terasaki H, et al. Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images. Invest Ophthalmol Vis Sci. 2014;55:3893–9.

    Article  PubMed  Google Scholar 

  31. Ruopp MD, Perkins NJ, Whitcomb BW, Schisterman EF. Youden Index and optimal cut-point estimated from observations affected by a lower limit of detection. Biom J. 2008;50:419–30.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, et al. Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup. Ophthalmology. 2021;128:443–52.

    Article  PubMed  Google Scholar 

  33. Spaide RF, Ledesma-Gil G, Gemmy Cheung CM. Intervortex venous anastomosis in pachychoroid-related disorders. Retina. 2021;41:997–1004.

    Article  PubMed  CAS  Google Scholar 

  34. Matsumoto H, Hoshino J, Arai Y, Mukai R, Nakamura K, Kikuchi Y, et al. Quantitative measures of vortex veins in the posterior pole in eyes with pachychoroid spectrum diseases. Sci Rep. 2020;10:19505.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  35. Demirel S, Ayaz RE, Yanik O, Batioglu F, Ozmert E, Iovino C, et al. Quantitative assessment of intervortex anastomosis in central serous chorioretinopathy and fellow eyes: Does the size of anastomotic vessels matter for the diagnosis?. Graefes Arch Clin Exp Ophthalmol. 2024;262:3509–17.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Terao N, Koizumi H, Kojima K, Yamagishi T, Yamamoto Y, Yoshii K, et al. Distinct aqueous humour cytokine profiles of patients with pachychoroid neovasculopathy and neovascular age-related macular degeneration. Sci Rep. 2018;8:10520.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Demirel S, Guran Begar P, Yanik O, Batioglu F, Ozmert E. Visualization of type-1 macular neovascularization secondary to pachychoroid spectrum diseases: a comparative study for sensitivity and specificity of indocyanine green angiography and optical coherence tomography angiography. Diagnostics (Basel). 2022;12:1368.

  38. Yanik O, Demirel S, Ozcan G, Batioglu F, Ozmert E. Qualitative and quantitative comparisons of type 1 macular neovascularizations between pachychoroid neovasculopathy and neovascular age-related macular degeneration using optical coherence tomography angiography. Eye (Lond). 2024;38:1714–21.

    Article  PubMed  CAS  Google Scholar 

  39. Miki A, Kusuhara S, Otsuji T, Kawashima Y, Miki K, Imai H, et al. Photodynamic therapy combined with anti-vascular endothelial growth factor therapy for pachychoroid neovasculopathy. PLoS One. 2021;16:e0248760.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  40. Iu LPL, Chan HY, Ho M, Lai FHP, Mak ACY, Wong RLM, et al. The contemporary role of photodynamic therapy in the treatment of pachychoroid diseases. J Ophthalmol. 2021;2021:6590230.

    Article  PubMed  PubMed Central  Google Scholar 

  41. Demirel S, Yanik O, Batioglu F, Ozmert E. Treatment outcomes of photodynamic therapy and findings predicting treatment success in pachychoroid-associated neovascularization. Eur J Ophthalmol. 2022;32:1662–70.

    Article  PubMed  Google Scholar 

  42. Klein R, Klein BE, Jensen SC, Meuer SM. The five-year incidence and progression of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology. 1997;104:7–21.

    Article  PubMed  CAS  Google Scholar 

  43. Yu JJ, Agron E, Clemons TE, Domalpally A, van Asten F, Keenan TD, et al. Natural history of drusenoid pigment epithelial detachment associated with age-related macular degeneration: age-related eye disease study 2 report no. 17. Ophthalmology. 2019;126:261–73.

    Article  PubMed  Google Scholar 

  44. Borrelli E, Reibaldi M, Bandello F, Lanzetta P, Boscia F. Ensuring the strict and accurate adherence to inclusion criteria in clinical trials for AMD is crucial. Eye (Lond). 2024;38:3037–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

SD was responsible for designing the protocol, writing the protocol and report, conducting the research, extracting and analysing data, interpreting results, writing. PAE contributed to writing the report, extracting and analysing data, interpreting results, and creating figures and tables. OY conducted the analyses and contributed to the design of the protocol. CG, JC and AK were drafting the work or reviewing it critically for important intellectual content. FB was responsible for designing the protocol and provided feedback on the report.

Corresponding author

Correspondence to Sibel Demirel.

Ethics declarations

Competing interests

The authors received no financial support for the research, authorship, and/or publication of this article. CMGC is a member of the Eye editorial board.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Demirel, S., Ellialtıoğlu, P.A., Yanık, Ö. et al. Non-indocyanine green angiography non-invasive differentiating features in the differential diagnosis of pachychoroid neovasculopathy and neovascular age-related macular degeneration: a sensitivity-specificity study. Eye (2025). https://doi.org/10.1038/s41433-025-04039-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41433-025-04039-y

Search

Quick links